The NK1 receptor antagonist SR140333 inhibits capsaicin-induced ERK phosphorylation in sensory neurons

被引:9
|
作者
Donnerer, J. [1 ]
Liebmann, I. [1 ]
机构
[1] Med Univ Graz, Inst Expt & Clin Pharmacol, AT-8010 Graz, Austria
关键词
intracellular signaling; ERK and STAT3 phosphorylation; vanilloid receptor; TRPV1; mRNA; NK1 receptor antagonist SR140333;
D O I
10.1159/000094022
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Primary sensory neurons respond to a vigorous excitation via the capsaicin receptor/TRPV1 cation channel by a phosphorylation of the Jak/STAT pathway as measured by phospho-STAT3, and of the Ras/Raf-MAPK pathway as measured by phospho-MAPK/ERK1/2. In the present investigation a possible involvement of NK1 receptors in the capsaicin-induced activation of these signal transduction pathways was investigated by protein extraction and Western immunoblotting. Phospho-MAPK/ERK1/2 and phdspho-STAT3 were determined in the dorsal root ganglia (DRG) and in the sciatic nerve of rats at 3 and 6 h following a systemic capsaicin treatment without or with the pretreatment of the selective NK1 receptor antagonist SR140333 (1 mg/kg s.c.; 3 h before capsaicin). Capsaicin evoked a threefold increase in phospho-ERK in the sciatic nerve and a two- to threefold increase in the DRG at 3 h and 6 h after the treatment. SR140333 markedly attenuated the capsaicin-induced increase in phosphorylated ERK. In the sciatic nerve the difference was significant at each individual time point (3 and 6 h, p < 0.001). In the DRG the difference was significant when the data at 3 h and 6 h were combined (p < 0.05), but not when individual time pointswere considered. Capsaicin evoked a four- to fivefold increase in phospho-STAT3 in the sciatic nerve and a twofold increase in the DRG at 3 and 6 h after the treatment. SR140333 less markedly attenuated the capsaicin-induced increase in phosphorylated STAT3: whereas in the sciatic nerve the difference was significant when the data at 3 h and 6 h were combined (p < 0.05), no such treatment effect of SR140333 was observed in the DRG. The expression of TRPV1 mRNA, a specific marker of capsaicin-sensitive small sensory neurons, was investigated by RT-PCR 4 days after the capsaicin treatment. Treatment of rats with SR140333 had no influence on the long-term downregulation of TRPV1 mRNA by capsaicin. Based on the present results and previous findings it can be postulated that the capsaicin-incluced ERK phosphorylation in sensory neurons is not a direct effect by capsaicin, but that rather substance P release from the stimulated sensory neurons with an NK1-mediated nerve growth factor (NGF) production is involved. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:144 / 149
页数:6
相关论文
共 50 条
  • [1] THE EFFECT OF THE NK1 RECEPTOR ANTAGONIST SR140333 ON CAPSAICIN-INDUCED PLASMA EXTRAVASATION (PE) IN THE MOUSE EAR
    STANLEY, JM
    CAMBRIDGE, H
    BRAIN, SD
    REGULATORY PEPTIDES, 1994, 51 (03) : 294 - 294
  • [2] Protection from DNBS-induced colitis by the tachykinin NK1 receptor antagonist SR140333 in rats
    Ursino, Maria Grazia
    Vasina, Valentina
    De Ponti, Fabrizio
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 603 (1-3) : 133 - 137
  • [3] Inhibition of the inflammatory response to antigen challenge in the hamster cheek pouch by the tachykinin NK1 receptor antagonist SR140333
    Hall, JM
    Palframan, R
    Reynia, S
    Brain, SD
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 : P274 - P274
  • [4] The effect of a tachykinin NK1 receptor antagonist, SR140333, on oedema formation induced in rat skin by venom from the Phoneutria nigriventer spider
    Palframan, RT
    Costa, SKP
    Wilsoncroft, P
    Antunes, E
    deNucci, G
    Brain, SD
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (02) : 295 - 298
  • [5] Inhibition of neurogenic oedema formation by a tachykinin NK1 receptor antagonist, SR140333, but not by a bradykinin antagonist, HOE140, in rat skin
    Towler, PK
    Brain, SD
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 : P203 - P203
  • [6] IN-VITRO AND IN-VIVO BIOLOGICAL-ACTIVITIES OF SR140333, A NOVEL POTENT NONPEPTIDE TACHYKININ NK1, RECEPTOR ANTAGONIST
    EMONDSALT, X
    DOUTREMEPUICH, JD
    HEAULME, M
    NELIAT, G
    SANTUCCI, V
    STEINBERG, R
    VILAIN, P
    BICHON, D
    DUCOUX, JP
    PROIETTO, V
    VANBROECK, D
    SOUBRIE, P
    LEFUR, G
    BRELIERE, JC
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 250 (03) : 403 - 413
  • [7] Effects of SR140333, a selective non-peptide NK1 receptor antagonist, on trigemino-thalamic nociceptive pathways in the rat
    Michaud, JC
    Alonso, R
    Gueudet, C
    Fournier, M
    Calassi, R
    Brelière, JC
    Le Fur, G
    Soubrié, P
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1998, 12 (01) : 88 - 94
  • [8] EFFECT OF A TACHYKININ NK1 RECEPTOR ANTAGONIST SR140333 ON EDEMA FORMATION INDUCED IN RAT SKIN BY VENOM FROM THE PHONEUTRIA-NIGRIVENTER SPIDER
    PALFRAMAN, R
    WILSONCROFT, P
    ANTUNES, E
    DENUCCIL, G
    BRAIN, SD
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 : P353 - P353
  • [9] The tachykinin NK1 receptor antagonist SR140333 prevents the increase of nerve growth factor in rat paw skin induced by substance P or neurogenic inflammation
    Amann, R
    Egger, T
    Schuligoi, R
    NEUROSCIENCE, 2000, 100 (03) : 611 - 615
  • [10] NEUROPHARMACOLOGICAL CHARACTERIZATION OF SR-140333, A NON PEPTIDE ANTAGONIST OF NK1 RECEPTORS
    JUNG, M
    CALASSI, R
    MARUANI, J
    BARNOUIN, MC
    SOUILHAC, J
    PONCELET, M
    GUEUDET, C
    EMONDSALT, X
    SOUBRIE, P
    BRELIERE, JC
    LEFUR, G
    NEUROPHARMACOLOGY, 1994, 33 (02) : 167 - 179